PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 26 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $348,000 | -18.7% | 117,242 | 0.0% | 0.21% | -25.6% |
| Q2 2022 | $428,000 | -41.0% | 117,242 | 0.0% | 0.28% | -22.6% |
| Q1 2022 | $726,000 | -23.6% | 117,242 | 0.0% | 0.36% | +4.1% |
| Q4 2021 | $950,000 | -45.6% | 117,242 | 0.0% | 0.34% | -31.7% |
| Q3 2021 | $1,747,000 | -78.1% | 117,242 | 0.0% | 0.50% | -75.4% |
| Q2 2021 | $7,975,000 | +1396.2% | 117,242 | 0.0% | 2.05% | +1550.8% |
| Q1 2021 | $533,000 | +112.4% | 117,242 | 0.0% | 0.12% | +113.8% |
| Q4 2020 | $251,000 | -8.1% | 117,242 | 0.0% | 0.06% | -47.3% |
| Q3 2020 | $273,000 | +15.7% | 117,242 | 0.0% | 0.11% | +61.8% |
| Q2 2020 | $236,000 | +177.6% | 117,242 | 0.0% | 0.07% | +172.0% |
| Q1 2020 | $85,000 | -72.7% | 117,242 | 0.0% | 0.02% | -63.2% |
| Q4 2019 | $311,000 | -21.5% | 117,242 | 0.0% | 0.07% | -43.3% |
| Q3 2019 | $396,000 | -43.6% | 117,242 | 0.0% | 0.12% | -36.2% |
| Q2 2019 | $702,000 | – | 117,242 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| Iron Gate Global Advisors LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |